Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesca Bonello

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Blood|November 27, 2025
Better together: epcoritamab boosts R2 in FLUmberto Vitolo, Francesca Bonello
Cancer Journal (Sudbury, Mass.)|September 22, 2021
Minimal Residual Disease in Multiple Myeloma: Ready for Prime Time?Roberto Mina, Francesca Bonello, Stefania Oliva
Frontiers in Oncology|March 31, 2022
Risk Stratification Before and During Treatment in Newly Diagnosed Multiple Myeloma: From Clinical Trials to the Real-World SettingFrancesca Bonello, Lorenzo Cani, Mattia D'Agostino
Cancers|October 29, 2020
Diagnostic and Therapeutic Challenges in the Management of Intermediate and Frail Elderly Multiple Myeloma PatientsFrancesca Bonello, Mario Boccadoro, Alessandra Larocca
Expert Opinion on Investigational Drugs|May 22, 2020
New drugs in early development for treating multiple myeloma: all that glitters is not goldLuca Bertamini, Francesca Bonello, Mario Boccadoro, et al.
Expert Review of Anticancer Therapy|November 30, 2016
Management of adverse events induced by next-generation immunomodulatory drug and proteasome inhibitors in multiple myelomaMarco Salvini, Francesca Bonello, Mario Boccadoro, et al.
Cancers|December 22, 2019
Therapeutic Monoclonal Antibodies and Antibody Products: Current Practices and Development in Multiple MyelomaFrancesca Bonello, Roberto Mina, Mario Boccadoro, et al.
Clinical Lymphoma, Myeloma & Leukemia|October 30, 2020
Daratumumab-Based Therapy for IgM Multiple Myeloma With Hyperviscosity Syndrome: A Case ReportRoberto Mina, Francesca Bonello, Francesca Gay, et al.
Leukemia Research|May 2, 2021
Can the dismal prognosis of patients with central nervous system plasma cell neoplasms be improved?Dario Ferrero, Francesca Bonello, Stefania Oliva, et al.
Clinical Hematology International|October 1, 2021
Moving Toward Continuous Therapy in Multiple MyelomaFrancesca Bonello, Giusy Cetani, Luca Bertamini, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Blood|November 27, 2025
Better together: epcoritamab boosts R2 in FLUmberto Vitolo, Francesca Bonello
Cancer Journal (Sudbury, Mass.)|September 22, 2021
Minimal Residual Disease in Multiple Myeloma: Ready for Prime Time?Roberto Mina, Francesca Bonello, Stefania Oliva
Frontiers in Oncology|March 31, 2022
Risk Stratification Before and During Treatment in Newly Diagnosed Multiple Myeloma: From Clinical Trials to the Real-World SettingFrancesca Bonello, Lorenzo Cani, Mattia D'Agostino
Cancers|October 29, 2020
Diagnostic and Therapeutic Challenges in the Management of Intermediate and Frail Elderly Multiple Myeloma PatientsFrancesca Bonello, Mario Boccadoro, Alessandra Larocca
Expert Opinion on Investigational Drugs|May 22, 2020
New drugs in early development for treating multiple myeloma: all that glitters is not goldLuca Bertamini, Francesca Bonello, Mario Boccadoro, et al.
Expert Review of Anticancer Therapy|November 30, 2016
Management of adverse events induced by next-generation immunomodulatory drug and proteasome inhibitors in multiple myelomaMarco Salvini, Francesca Bonello, Mario Boccadoro, et al.
Cancers|December 22, 2019
Therapeutic Monoclonal Antibodies and Antibody Products: Current Practices and Development in Multiple MyelomaFrancesca Bonello, Roberto Mina, Mario Boccadoro, et al.
Clinical Lymphoma, Myeloma & Leukemia|October 30, 2020
Daratumumab-Based Therapy for IgM Multiple Myeloma With Hyperviscosity Syndrome: A Case ReportRoberto Mina, Francesca Bonello, Francesca Gay, et al.
Leukemia Research|May 2, 2021
Can the dismal prognosis of patients with central nervous system plasma cell neoplasms be improved?Dario Ferrero, Francesca Bonello, Stefania Oliva, et al.
Clinical Hematology International|October 1, 2021
Moving Toward Continuous Therapy in Multiple MyelomaFrancesca Bonello, Giusy Cetani, Luca Bertamini, et al.
Pageof 3